OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e229317-e229317
Open Access | Times Cited: 203

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 67

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 44

The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemic
Steven Santos, Matthew A. Humbard, Anastasia S. Lambrou, et al.
The Lancet Public Health (2025) Vol. 10, Iss. 1, pp. e47-e57
Closed Access | Times Cited: 1

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 57

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2
Harald Brüssow
Microbial Biotechnology (2022) Vol. 15, Iss. 7, pp. 1927-1939
Open Access | Times Cited: 54

Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37

Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
Sang Woo Park, Kaiyuan Sun, Sam Abbott, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 22
Open Access | Times Cited: 33

The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review
Aparajita Sarkar, Sara Omar, Aya Alshareef, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 24

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13

Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8

Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater
Wei Lin Lee, Federica Armas, Flavia Guarneri, et al.
Water Research (2022) Vol. 221, pp. 118809-118809
Open Access | Times Cited: 35

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6

Child Transmission of SARS-CoV-2 Throughout the Pandemic: An Updated Systematic Review and Meta-Analysis
Eugene D. Kwon, Gabriel Blank, Samantha Y. Starkey, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access

Bridging Epidemiological and Malthusian Fitness: Insights into SARS-CoV-2 Dynamics
Hugo Fort
Next research. (2025), pp. 100223-100223
Closed Access

Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus
Ana A. Weil, Kyle G Luiten, Amanda M. Casto, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
Anna L. Beukenhorst, Clarissa M. Koch, Christoforos Hadjichrysanthou, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 3, pp. 237-242
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top